Rym Ben-Hamadi

Suggest Changes
Learn More
BACKGROUND Treatment utilization/costs and work performance for persons with major depressive disorder (MDD) by severity of illness is not well documented. METHODS Using National Comorbidity(More)
OBJECTIVE Compare treatment patterns for patients with schizophrenia treated with olanzapine versus quetiapine in the Pennsylvania Medicaid population. METHODS Patients (18-64 years) with a(More)
BACKGROUND Major depressive disorder is the most common type of depression, affecting 6.6% of adults in the United States annually. Citalopram and escitalopram are common second-generation(More)
OBJECTIVE To estimate, from a third-party payer's perspective, the effects of switching from escitalopram to citalopram, after the generic entry of citalopram, on hospitalization and healthcare costs(More)